Combining our time-tested abilities in developed and emerging international markets

The Fund invests primarily in companies both in developed markets excluding the United States (the “international value portfolio”) and in emerging markets (the “emerging markets portfolio”). Causeway allocates substantially all of the Fund’s assets between the international value portfolio and the emerging markets portfolio using a proprietary asset allocation model.

International Value Portfolio: The international value portfolio consists primarily of common stocks of companies located in developed countries outside the US. Normally, the majority of this portfolio invests in companies that pay dividends or repurchase their shares. The international value portfolio may also invest in companies located in emerging (less developed) markets.

Emerging Markets Portfolio: The emerging markets portfolio is normally invested in equity securities of companies located in emerging (less developed) markets and other investments that are tied economically to emerging markets. Generally, these investments include common stock, preferred and preference stock, American Depositary Receipts, European Depositary Receipts, Global Depositary Receipts, and exchange-traded funds that invest in emerging markets securities.

YTD Return*
+33.89%
Nav*
$20.78, -0.11
Inception
December 31, 2009
Cusip
14949Q107
Benchmark
MSCI ACWI ex US
Minimum Investment
$1,000,000
Sales Charge
None
Gross Expense Ratio
0.99%
Net Expense Ratio
0.95%
*As of December 12, 2025
**Contractual fee waivers are in effect until 1/31/2026.

Strategy overview

The portfolio managers discuss our International Opportunities strategy.

Portfolio managers

Fundamental Portfolio Manager
Fundamental Portfolio Manager
Quantitative Portfolio Manager
President
Head of Fundamental Research
Fundamental Portfolio Manager
Head of Quantitative Research
Quantitative Portfolio Manager
Quantitative Portfolio Manager
Chief Executive Officer
Fundamental Portfolio Manager
Fundamental Portfolio Manager
Fundamental Portfolio Manager
Quantitative Portfolio Manager
Fundamental Portfolio Manager
Fundamental Portfolio Manager

Performance

Table Header QTD YTD 1 year3 years5 years10 years Since inception
Fund 2.3%30.9%29.7%20.7%12.1%8.6%7.4%
MSCI ACWI ex US 2.0%28.5%26.0%15.9%8.4%7.9%6.1%
Table Header QTD YTD 1 year3 years5 years10 years Since inception
Fund 2.3%30.9%29.7%20.7%12.1%8.6%7.4%
MSCI ACWI ex US 2.0%28.5%26.0%15.9%8.4%7.9%6.1%
Table Header QTD YTD 1 year3 years5 years10 years Since inception
Fund 6.3%28.0%19.3%27.2%15.2%8.8%7.3%
MSCI ACWI ex US 6.9%26.0%16.4%20.7%10.3%8.2%6.0%
Table Header QTD YTD 1 year3 years5 years10 years Since inception
Fund 6.3%28.0%19.3%27.2%15.2%8.8%7.3%
MSCI ACWI ex US 6.9%26.0%16.4%20.7%10.3%8.2%6.0%
Table Header 202420232022202120202019201820172016201520142013201220112010
Fund 8.6%24.8%-11.1%6.6%5.4%21.7%-18.4%29.6%2.0%-6.1%-3.7%17.8%24.6%-12.6%15.4%
MSCI ACWI ex US 5.5%15.6%-16.0%7.8%10.7%21.5%-14.2%27.2%4.5%-5.7%-3.9%15.3%16.8%-13.7%11.2%
Table Header
Fund
MSCI ACWI ex US
202420232022202120202019201820172016201520142013201220112010
8.6%24.8%-11.1%6.6%5.4%21.7%-18.4%29.6%2.0%-6.1%-3.7%17.8%24.6%-12.6%15.4%
5.5%15.6%-16.0%7.8%10.7%21.5%-14.2%27.2%4.5%-5.7%-3.9%15.3%16.8%-13.7%11.2%

Portfolio (as of November 30, 2025)

Benchmark: MSCI ACWI ex US
Asset Allocation
Table Header Fund
Stocks 98.8%
Cash 1.2%
Fund Characteristics
Table Header Fund Benchmark
No. of holdings 232 1973
Weighted avg. market cap (US $MM) $116,027 $122,641
FY2 price/earnings 11.8 14.5
Price/book value 1.7 2.2
Net assets $365,969,815 -
TOP 10 HOLDINGS
Security Country Percent
Kering SA France 3.9
Taiwan Semiconductor Manufacturing Co., Ltd. Taiwan 2.9
AstraZeneca PLC United Kingdom 2.7
Alstom SA France 2.5
Barclays PLC United Kingdom 2.3
Roche Holding AG Switzerland 2.3
Reckitt Benckiser Group Plc United Kingdom 2.3
Tencent Holdings Ltd. China 2.2
Renesas Electronics Corp. Japan 2.2
BNP Paribas SA France 1.8

A “weighted average” measures a characteristic by the market capitalization of each stock. Price/book ratio is the weighted average of the price/book ratios of all the stocks in a portfolio. The P/B ratio of a company is calculated by dividing the market price of its stock by the company’s per-share book value. The price/earnings ratio is the weighted average of the price/earnings ratios of the stocks in a portfolio. The FY2 P/E ratio is a forward P/E ratio using a next-twenty-four months EPS estimate in the denominator.

Holdings are subject to change.

SECTOR WEIGHTS
Sector Fund Benchmark
Financials 18.7% 24.9%
Information Technology 16.9% 14.3%
Industrials 13.2% 14.6%
Consumer Discretionary 11.3% 10.1%
Health Care 10.7% 8.1%
Consumer Staples 7.4% 6.2%
Materials 7.0% 6.7%
Communication Services 6.3% 5.8%
Utilities 2.6% 3.2%
Energy 2.1% 4.5%
Real Estate 1.5% 1.6%
Equity Funds 1.1% 0.0%
TOP 10 COUNTRIES
Country Fund Benchmark
United Kingdom 20.2% 9.0%
France 14.4% 6.6%
China 10.2% 8.8%
Japan 7.1% 13.8%
Taiwan 6.7% 6.1%
Germany 6.4% 5.8%
South Korea 5.3% 3.7%
Netherlands 4.8% 3.0%
India 4.8% 4.8%
United States 2.5% 0.0%
Regional Allocation
  • Euro 29.2%
  • Emerging Asia 27.6%
  • Europe - Other 25.0%
  • Pacific 7.8%
  • North America 4.2%
  • Emerging Europe, Middle East, Africa 2.2%
  • Emerging Latin America 1.8%
  • Multi Region 1.1%

Commentary (As of November 30, 2025)

Highlights

  • Global equity markets were broadly flat for November, but style performance diverged, with value stocks outperforming growth in certain regions.
  • US tariff negotiations with China are ongoing and the situation is complex – the average effective tariff rate far exceeds the reciprocal tariff rate due to various other tariffs on specific goods. We are overweight Chinese stocks in the Fund due in part to compelling valuation and growth characteristics.
  • In the developed markets portion of the portfolio, we are investing in companies with, in our view, durable pricing power, strong brands, and resilient product pipelines, and we view periods of temporary underperformance as opportunities to build positions at compelling valuations. We aim to hold management teams accountable for accelerating operational restructuring and improving shareholder returns. We remain confident that active management and disciplined stock selection should continue to uncover attractive opportunities across global markets.

Portfolio Attribution

The Causeway International Opportunities Fund (“Fund”) on a net asset value basis, outperformed the Index during the month. On a gross return basis, Fund holdings in the capital goods, banks, and pharmaceuticals & biotechnology industry groups contributed to relative performance. Holdings in the materials, consumer durables & apparel, and consumer services industry groups detracted from relative performance. The greatest contributors to absolute returns included pharmaceuticals & biotechnology company, Roche Holding AG (Switzerland), pharmaceutical company, AstraZeneca PLC (United Kingdom), and banking & financial services company, BNP Paribas SA (France). The largest detractors from absolute returns included semiconductor manufacturer, Taiwan Semiconductor Manufacturing Co., Ltd. (Taiwan), multinational luxury conglomerate, Kering SA (France), and cruise ship operator, Carnival Corp. (United States).

We use a proprietary quantitative equity allocation model that assists the portfolio managers in determining the weight of emerging versus developed markets in the Fund. Our allocation relative to the weight of emerging markets in the Index is currently overweight. We identify five primary factors as most indicative of the ideal allocation target: valuation, quality, earnings growth, macroeconomic, and risk aversion. Our growth and macroeconomic metrics are currently positive for emerging markets. Our quality metric, which includes such measures as profit margins and return on equity, is also positive. Our risk aversion metric is currently negative for emerging markets and our valuation metric is neutral.

Investment Outlook

Market trends in 2025 year-to-date point to a notable shift in investor sentiment and capital rotation toward non-US equity markets. European fund inflows accelerated in the first half of the year, helping fuel the 12% appreciation of the euro versus the US dollar through the end of November. Year-to-date, US dollar weakness accounts for much of the outperformance of international markets. This strong developed international equity outperformance in US-dollar terms has likely renewed investor interest in undervalued European, UK, and Japanese equities. The current rise of international value indices over growth provides a constructive backdrop for our value-oriented investment style. Among the leading non-US sectors in 2025, we see continued upside potential in financials, industrials, information technology, and consumer staples. Several of the portfolio’s lagging stocks this year appear well-positioned to outperform in 2026 as management teams execute on earnings and cash-flow improvements, inspiring market confidence. In the developed markets portion of the portfolio, we are investing in companies with, in our view, durable pricing power, strong brands, and resilient product pipelines, and we view periods of temporary underperformance as opportunities to build positions at compelling valuations. We aim to hold management teams accountable for accelerating operational restructuring and improving shareholder returns. We remain confident that active management and disciplined stock selection should continue to uncover attractive opportunities across global markets.

In emerging markets, the tariff outlook for EM exports has generally improved, which has also bolstered EM assets. Reciprocal tariff rates in South Korea and Taiwan have been reduced and many goods, notably semiconductors, are excluded from the reciprocal tariffs currently. US tariff negotiations with China are ongoing and the situation is complex – the average effective tariff rate far exceeds the reciprocal tariff rate due to various other tariffs on specific goods. We are overweight Chinese stocks in the Fund due in part to compelling valuation and growth characteristics. In South Korea, corporate governance continues to improve. The Korean parliament passed an amendment to the Korean Commercial Act, which expands companies’ boards of directors’ fiduciary duties to also consider the interests of minority shareholders. We are overweight South Korean stocks in the Fund due in part to favorable valuation, growth, price momentum, and top-down characteristics.

The market commentary expresses the portfolio managers’ views as of the date of this report and should not be relied on as research or investment advice regarding any stock. These views and the fund holdings and characteristics are subject to change. There is no guarantee that any forecasts made will come to pass. Any securities identified and described in this report do not represent all of the securities purchased, sold or recommended for client accounts. The reader should not assume that an investment in the securities identified was or will be profitable. Diversification does not protect against market loss. Current and future holdings are subject to risk. Investing in ETFs is subject to the risks of the underlying funds. Investments in smaller companies typically exhibit higher volatility. Asset allocation may not protect against market risk. International and emerging markets investments may involve risk of capital loss from unfavorable fluctuation in currency values, from differences in generally accepted accounting principles or from social, economic or political instability in other nations. Emerging markets and smaller companies involve additional risks and higher volatility.

Distributions

Table Header Dividends Short-term capital gains Long-term capital gains
2024 $0.5452 $0.1170 $0.8970
2023 $0.4007 $0.0000 $0.0282
2022 $0.3603 $0.0000 $0.0000
2021 $0.2400 $0.0000 $0.0000
2020 $0.1974 $0.0000 $0.0000
2019 $0.3502 $0.0000 $0.0327
2018 $0.2904 $0.0000 $0.0327
2017 $0.2145 $0.0000 $0.0000
2016 $0.4494 $0.0000 $0.0000
2015 $0.1623 $0.0107 $0.0199
2014 $0.0000 $0.0000 $0.4943
2013 $0.1266 $0.0001 $0.0739
2012 $0.2451 $0.0000 $0.0190
2011 $0.2756 $0.0000 $0.0303
2010 $0.1858 $0.0000 $0.1712

Distributions are per share. Distribution amounts are based on gains and losses realized and income earned by the Fund through October 31 (or earlier under certain circumstances).

Documents

Fund information:

Forms: